Chamaemelum nobile L. aqueous extract represses endogenous glucose production and improves insulin sensitivity in streptozotocin-induced diabetic mice

American Journal of Pharmacology and Toxicology

Volumn 2, Issue 3, 2007, Pages 116-122

  Lemhadri, Ahmed ^a   Burcelin, Remy ^b   Sulpice, Thierry ^c   Eddouks, Mohamed ^a  

^a MOULAY ISMAIL UNIVERSITY   (Morocco)

^b CHU RANGUEIL   (France)

^c Physiogenex   (France)

Author keywords

Endogenous glucose production; Euglycemic hyperinsulinemic clamp; Insulin sensivity; Mice; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; CHAMAEMELUM NOBILE EXTRACT; GLUCOSE; INSULIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CHAMAEMELUM; CHAMAEMELUM NOBILE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; DRUG RESPONSE; DRUG SCREENING; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; INSULIN SENSITIVITY; MALE; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; REPEATED DRUG DOSE; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES;

CHAMAEMELUM NOBILE; MUS;

EID: 38749094091     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2007.116.122     Document Type: Article

References (47)

1. Wild, S., G. Roglic, A. Green, R. Sicree, and H. King, 2004. Global prevalence of diabetes. Diabetes Care, 27: 1047-1053.
2. Yki-Järvinen, H and V.A. Koivisto, 1986. Natural course of insulin resistance in type 1 diabetes. New England Journal of Medicine, 325: 224-230.
3. Reaven, G.M.,1995. Pathophysiology of insulin resistance in human disease. Pharmacological Reviews, 75(3): 473-486.
4. Greenbaum, C.J., 2002. Insulin resistance in type 1 diabetes. Diabetes/ Metabolism Research and Reviews, 18: 192-200.
5. Lebovitz, H.E., 2001. Insulin resistance: definition and consequences. Experimental and Clinical Endocrinology and Diabetes, 109(2): S135-S148.
6. Yki-Järvinen, H., M.R. Taskinen and T. Kiviluoto, T, 1984. Site of insulin resistance in type 1 diabetes: insulin mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. Journal of Clinical Endocrinology and Metabolism, 59: 1183-1192.
7. Nishimura, H., H. Kuzuya and M. Okamoto, 1984. Post-receptor defect in insulin action in streptozotocin-induced diabetic rats. American Journal of Physiology (Endocrinology and Metabolism), 19: E624-E630.
8. Iwanishi, M and M. Kobayashi, 1993. Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats. Metabolism, 42: 1017-1021.
9. Eddouks, M., M. Maghrani, A. Lemhadri, M.L. Ouahidi and H. Jouad, 2002. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). Journal of Ethnopharmacology, 82(2-3): 97-103.
10. Eddouks, M., A. Lemhadri, N.A. Zeggwagh, J.B. Michel, 2005. Potent hypoglycaemic activity of the aqueous extract of Chamaemelum nobile in normal and streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice, 67: 189-195.
11. Konig, G.M., A.D. Wright, W.J. Keller, R.L. Judd, S. Bates and C. Day, 1998. Hypoglycaemic activity of an HMG-containing flavonoid glucoside, chamaemeloside, from Chamaemelum nobile. Planta Medica, 64(7): 612-614.
12. Eisenbarth, G.S., 1986. Type I diabetes mellitus: a chronic autoimmune disease. New England Journal of Medicine, 314: 1360-1368.
13. Hother-Nielson, O and H. Beck-Nielson, 1990. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia, 33: 603-610.
14. DeFronzo, R.A., J.D. Tobin and R. Andres, 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology (Metab Gastrointest Physiol), 237: E214-E223.
15. Burcelin, R., V. Crivelli, A. Dacosta, A. Roy-Tirelli and B. Thoreus, 2002. Heterogeneous metabolic adaptation of C57BL/6I mice to high-fat diet. American Journal of Physiology (Endocrinology and Metabolism), 282(4): E834-E842.
16. Thorvaldson, L., M. Holstad and S. Sandler, 2003. Cytokine release by murine spleen cells following multiple low dose streptozotocin-induced diabetes and treatment with a TNF-alpha transcriptional inhibitor. International Immunopharmacology, 3: 1609-1617.
17. Eddouks, M., H. Jouad, M. Maghrani, A. Lemhadri, and R. Burcelin, 2003. Inhibition of endogenous glucose production accounts for hypoglycemic effect of Spergularia purpurea in streptozotocin mice. Phytomedicine, 10: 594-599.
18. DeFronzo, R.A., D. Simonson and E. Ferrannini, 1982. Hepatic and peripheral insulin resistance: a common feature of type 2 (non insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 23: 313-319.
19. Burcelin, R., M. Eddouks, J. Maury, J. Kande, R. Assan and J. Girard, 1995. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats. Diabetologia, 38(3): 283-90.
20. Baquer, N.Z., D. Gupta and J. Raju, 1998. Regulation of metabolic pathways in liver and kidney during experimental diabetes: effect of antidiabetic compounds. Indian Journal of Clinical Biochemistry, 13: 63-80.
21. Burcelin, R., M. Eddouks, J. Kande, R. Assan and J. Girrard 1992. Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinemia liver of diabetic rats. Biochemical Journal, 288: 675-679.
22. Cheng, J.T., I.M. Liu, T.C. Chi, H.C. Su and C.G. Chang, 2001. Metformin-like effects of Quei Fu Di Huang Wan, a Chinese mixture, on streptozotocin-induced diabetic rats. Hormone and Metabolism Research, 33: 727-732.
23. Grover JK, V. Vats and S. Yadav, 2002. Effect of feeding aqueous extract of Pterocarpus marsupium on glycogen content of tissues and the key enzymes of carbohydrate metabolism. Molecular and Cellular Chemistry, 241(1-2): 53-59.
24. Waltner-Law, M.E., X. Wang, B.K. Law, K.R. Hall, M. Nawano and D.K. Grannel, 2002. Epigallatocatechin gallate, a constituent of green tea, represses hepatic glucose production. The Journal of Biochemical Chemistry, 277(38): 34933-34940.
25. Koyama, Y., K. Abe, Y. Sano, Y. Ishizaki, M. Njelekela, Y. Shoj, Y. Hara and M. Isemura, 2004. Effects of green tea gene expression of hepatic gluconeogenic enzymes in vivo. Planta Medica, 70: 1100-1102.
26. Prasad, R.C., B. Herzog, B. Boone, L. Sims and M. Waltner-Law, 2005. An extract of Syzigium aromaticum represses genes encoding hepatic gluconeogenic enzymes. Journal of Ethnopharmacology, 96: 295-301.
27. Bollen, M., S. Keppens and W. Stalmans, 1998. Specific features of glycogen metabolism in the liver. Biochemical Journal, 336: 19-31.
28. Blondel, O., D. Bailbe and B. Portha, 1989. In vivo insulin resistance in streptozotocin-diabetic rats-evidence for reversal following oral vanadate treatment. Diabetologia, 32(3): 185-190.
29. Blondel, O and B. Portha, 1989. Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats. Diabetes&Metabolism (Paris), 15(6): 382-387.
30. Tominaga, M., M. Kimura, and K. Sygiyama, 1995. Effects of Sheishin-renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice, 29: 11-17.
31. Smith, D., L. Rossetti, E. Ferrannini,., et al., 1987. In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism, 36: 1167-1174.
32. Chakrabarti, R., R.K.V. Damarla, R. Mullangi., et al., 2006. Insulin sensitizing property of Indigofera mysorensis extract. Journal of Ethnopharmacology, 105: 102-106.
33. Attele, AS, Y.P. Zhou, J.T. Xie., et al., 2002. Antidiabetic effects of Panax ginseng berry extract flower extract: activation of PPAR-γ and identification of an active component. Diabetes, 51: 1851-1858.
34. Liu, T.P., I.M. Liu and J.T. Cheng, 2005. Improvement of insulin resistance by Panax ginseng in fructose-rich chow-fed rats. Hormone and Metabolism Research, 37: 146-151.
35. Vijayakumar, M.V., S. Singh, R.R. Chhipa and M.K. Bhat; 2005. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. British Journal of Pharmacology, 146: 41-48.
36. Hou, Z., Z. Zhang and H. Wu, 2005. Effect of Sanguis draxonis (a Chinese traditional herb) on the formation of insulin resistance in rats. Diabetes Research and Clinical Practice 2005; 68(1): 3-11.
37. Liu, T.P., C.S. Lee, S.S. Liou, I.M. Liu and J.T. Cheng, 2005. Improvement of insulin resistance by Acanthopanax senticosus root in fructose-rich chow-fed rats. Clinical and Experimental Pharmacology andPhysiology, 32: 649-654.
38. Hu, X., J.Sato, Y. Oshida, M. Xu, G. Bajotto and Y. Sato, 2003. Effect, of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Research and- Clinical Practice, 59: 103-111.
39. Qin, B., M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida and Y. Sato, 2004. Gosha-jinki-gan (a herbal complex) corrects abnormal insulin signalling. Evidenced-based Complementary and Alternative Medicine, 1(3): 269-276.
40. Uno, T., I. Ohsawa, M. Tokudome and Y. Sato, 2005. Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes Diabetes Research and Clinical Practice, 69(2): 129-135.
41. Cameron-Smith, D., R. Habito, M. Barnett and G.R. Collier, 1996. Dietary Guar gum improves insulin sensitivity in Streptozotocin-indriced diabetic rats. Journal of Nutrition, 127: 359-364.
42. Qin, B., M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida and Y. Sato, Y. 2003. Cinnamon extract (traditional herb) potentiates in vivo insulin regulated glucose utilization via enhancing insulin signalling in rats. Diabetes Research and Clinical Practice, 62: 139-148.
43. Choi, S.B., J.D. Wha and S. Park, S., 2004. The insulin sensitizing effect of homoisoflavone-enriched fraction in Liriope platyphylla Wang et Tang via P13-kinase pathway. Life Sciences, 75: 2653-2664
44. Wilson, T.M., J.E. Cobb, D.J. Cowan, et al., 1996. The structure activity relationship between peroxisome proliferator activated receptor-γ agonism and the hyperglycemic activity of thiazolidinediones. Journal of Medicine and Chemistry, 39: 665-668.
45. Saltiel, A.R and J.M. Olefsky,1996. Thiazolidinediones in the treatment of insulin resistance in type 2 diabetes. Diabetes, 45: 1661-1669.
46. Huang, T.H.W., G. Peng, B.P. Kota, et al., 2005. Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component. Toxicology and Applied Pharmacology, 2(1): 160-169.
47. Anandharajan, R., K. Pathmanathan, N. Shankernarayanan, R.A. Vishwakarma. and A. Balakrishnan, 2005. Upregulation of Glut-4 and PPAR-γ by an isoflavone from Pterocarpus marsupium on L6 myotubes: a possible mechanism of action. Journal of Ethnopharmacology, 97: 253-260.